Accordage Med: what changed
Accordage Med
Largest movements
- Cash +€32,511
up €32,511 (+98.0%), from €33,163 to €65,673
mainly Net result for the year (+€32,476) and Provisions (+€2,893)
- Receivables within one year +€1,816
up €1,816 (+11.2%), from €16,215 to €18,031
of which Other amounts receivable: +€1,799
- Reserves +€31,643
up €31,643 (+140%), from €22,528 to €54,171
- Provisions +€2,893
up €2,893 (+13.1%), from €22,147 to €25,040
- Provisions -€19,255
down €19,255 (-86.9%), from €22,147 to €2,893
- Financial charges +€16,448
up €16,448 (+450%), from €3,653 to €20,100
- Gross operating margin +€3,315
up €3,315 (+5.2%), from €64,007 to €67,322
- Taxes -€1,937
down €1,937 (-13.1%), from €14,820 to €12,883
- Financial income +€1,031
new in 2025: €1,031
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €49,377 | €83,844 | +€34,467 | +69.8% |
| Current assets | 29/58 | €49,377 | €83,844 | +€34,467 | +69.8% |
| Amounts receivable within one year | 40/41 | €16,215 | €18,031 | +€1,816 | +11.2% |
| Trade receivables | 40 | - | €17 | +€17 | |
| Other amounts receivable | 41 | €16,215 | €18,014 | +€1,799 | +11.1% |
| Cash at bank and in hand | 54/58 | €33,163 | €65,673 | +€32,511 | +98.0% |
| Deferred charges and accrued income | 490/1 | - | €140 | +€140 | |
| Total equity and liabilities | 10/49 | €49,377 | €83,844 | +€34,467 | +69.8% |
| Equity | 10/15 | €24,528 | €56,171 | +€31,643 | +129% |
| Contributions | 10/11 | €2,000 | €2,000 | = | 0.0% |
| Reserves | 13 | €22,528 | €54,171 | +€31,643 | +140% |
| Distributable reserves | 133 | €22,528 | €54,171 | +€31,643 | +140% |
| Provisions and deferred taxes | 16 | €22,147 | €25,040 | +€2,893 | +13.1% |
| Provisions for liabilities and charges | 160/5 | €22,147 | €25,040 | +€2,893 | +13.1% |
| Other liabilities and charges | 164/5 | €22,147 | €25,040 | +€2,893 | +13.1% |
| Amounts payable | 17/49 | €2,702 | €2,633 | -€69 | -2.6% |
| Amounts payable within one year | 42/48 | €2,702 | €2,633 | -€69 | -2.6% |
| Trade debts | 44 | €43 | - | -€43 | |
| Suppliers | 440/4 | €43 | - | -€43 | |
| Taxes, remuneration and social security | 45 | €2,058 | €2,050 | -€8 | -0.4% |
| Taxes | 450/3 | €258 | €250 | -€8 | -3.0% |
| Remuneration and social security | 454/9 | €1,800 | €1,800 | = | 0.0% |
| Other amounts payable | 47/48 | €601 | €583 | -€18 | -3.0% |
| Provisions for liabilities and charges: additions (uses and reversals) | 635/8 | €22,147 | €2,893 | -€19,255 | -86.9% |
| Gross operating margin | 9900 | €64,007 | €67,322 | +€3,315 | +5.2% |
| Operating profit (loss) | 9901 | €41,860 | €64,429 | +€22,570 | +53.9% |
| Financial income | 75/76B | - | €1,031 | +€1,031 | |
| Recurring financial income | 75 | - | €1,031 | +€1,031 | |
| Financial charges | 65/66B | €3,653 | €20,100 | +€16,448 | +450% |
| Recurring financial charges | 65 | €3,653 | €20,100 | +€16,448 | +450% |
| Profit (loss) for the period before taxes | 9903 | €38,207 | €45,359 | +€7,152 | +18.7% |
| Income taxes | 67/77 | €14,820 | €12,883 | -€1,937 | -13.1% |
| Profit (loss) for the period | 9904 | €23,387 | €32,476 | +€9,089 | +38.9% |
| Profit (loss) for the period to be appropriated | 9905 | €23,387 | €32,476 | +€9,089 | +38.9% |
Next steps
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 5 November 2026 via checked.be.